Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Current Opinion in Oncology
|
January 10, 2001
Nonablative allogeneic hematopoietic stem cell transplantation
R D Dansey, R D Baynes
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 20, 1990
Captopril in hypertensive black men in southern Africa
R L Cowie, R D Dansey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
April 21, 1990
Features of systemic sclerosis (scleroderma) in South African goldminers
R L Cowie, R D Dansey
Leukemia & Lymphoma
|
July 28, 2016
Idarubicin plus Cytarabine versus Doxorubicin plus Cytarabine in Induction Therapy for Acute Non- Lymphoid Leukaemia: A Randomized Trial
W R Bezwoda, R D Dansey
Lancet (London, England)
|
December 9, 1989
Deep-vein thrombosis and pulmonary tuberculosis
R L Cowie, R D Dansey, M Hay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1995
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial
W R Bezwoda, L Seymour, R D Dansey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
April 18, 1992
Seizures and neurocysticercosis in black men
R D Dansey, M Hay, R L Cowie
Breast Cancer Research and Treatment
|
January 1, 1995
P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancer
L Seymour, W R Bezwoda, R D Dansey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 3, 1987
Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer
W R Bezwoda, C S Hesdorffer, R D Dansey
British Journal of Cancer
|
September 1, 1994
Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease
L K Seymour, R D Dansey, W R Bezwoda
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Current Opinion in Oncology
|
January 10, 2001
Nonablative allogeneic hematopoietic stem cell transplantation
R D Dansey, R D Baynes
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 20, 1990
Captopril in hypertensive black men in southern Africa
R L Cowie, R D Dansey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
April 21, 1990
Features of systemic sclerosis (scleroderma) in South African goldminers
R L Cowie, R D Dansey
Leukemia & Lymphoma
|
July 28, 2016
Idarubicin plus Cytarabine versus Doxorubicin plus Cytarabine in Induction Therapy for Acute Non- Lymphoid Leukaemia: A Randomized Trial
W R Bezwoda, R D Dansey
Lancet (London, England)
|
December 9, 1989
Deep-vein thrombosis and pulmonary tuberculosis
R L Cowie, R D Dansey, M Hay
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1995
High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial
W R Bezwoda, L Seymour, R D Dansey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
April 18, 1992
Seizures and neurocysticercosis in black men
R D Dansey, M Hay, R L Cowie
Breast Cancer Research and Treatment
|
January 1, 1995
P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancer
L Seymour, W R Bezwoda, R D Dansey
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|
October 3, 1987
Use of mitoxantrone-based combination chemotherapy regimens as first-line treatment for advanced breast cancer
W R Bezwoda, C S Hesdorffer, R D Dansey
British Journal of Cancer
|
September 1, 1994
Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease
L K Seymour, R D Dansey, W R Bezwoda
Page
of 3